Investor Relations

OPKO Health Announces Leadership Changes at BioReference Laboratories more »

OPKO'S GeneDx Announces Research Collaboration with Radboud University Medical Center more »

OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertrophy more »

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results more »

Email Alert Registration

Please fill out the form below to sign up for event notifications. Providing this information will allow you to gain full access to our online Investor Relations services. * Required fields

 
 
 
 
 
 


 
This helps OPKO Health, Inc. prevent automated submissions.

Email  Sign up for email alerts